169 related articles for article (PubMed ID: 17850390)
1. A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.
Hadaschik BA; Black PC; Sea JC; Metwalli AR; Fazli L; Dinney CP; Gleave ME; So AI
BJU Int; 2007 Dec; 100(6):1377-84. PubMed ID: 17850390
[TBL] [Abstract][Full Text] [Related]
2. Bioluminescence imaging to monitor bladder cancer cell adhesion in vivo: a new approach to optimize a syngeneic, orthotopic, murine bladder cancer model.
Jurczok A; Fornara P; Söling A
BJU Int; 2008 Jan; 101(1):120-4. PubMed ID: 17888045
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of disease progression by bioluminescence imaging and magnetic resonance imaging in an animal model of hematologic malignancy.
Inoue Y; Izawa K; Tojo A; Nomura Y; Sekine R; Oyaizu N; Ohtomo K
Exp Hematol; 2007 Mar; 35(3):407-15. PubMed ID: 17309821
[TBL] [Abstract][Full Text] [Related]
4. Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.
Hadaschik BA; Jackson J; Fazli L; Zoubeidi A; Burt HM; Gleave ME; So AI
BJU Int; 2008 Aug; 102(5):610-6. PubMed ID: 18384625
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
[TBL] [Abstract][Full Text] [Related]
6. Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin.
Hadaschik BA; Adomat H; Fazli L; Fradet Y; Andersen RJ; Gleave ME; So AI
Clin Cancer Res; 2008 Mar; 14(5):1510-8. PubMed ID: 18316576
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
Hadaschik BA; Zhang K; So AI; Fazli L; Jia W; Bell JC; Gleave ME; Rennie PS
Cancer Res; 2008 Jun; 68(12):4506-10. PubMed ID: 18559493
[TBL] [Abstract][Full Text] [Related]
8. Mouse orthotopic models for bladder cancer research.
Chan E; Patel A; Heston W; Larchian W
BJU Int; 2009 Nov; 104(9):1286-91. PubMed ID: 19388981
[TBL] [Abstract][Full Text] [Related]
9. [Characterization of a novel transplantable orthotopic nude mouse model with xenografted human bladder transitional cell tumor (BIU-87)].
Li C; Yan RP; Yuan GH; Feng YG; Wang JS; Gao X; Huang YS; Zhou JB; Xie SS
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):733-6. PubMed ID: 17366782
[TBL] [Abstract][Full Text] [Related]
10. Validation of intratracheal instillation of lung tumour cells in mice using single photon emission computed tomography/computed tomography imaging.
Buckle T; van Leeuwen FW
Lab Anim; 2010 Jan; 44(1):40-5. PubMed ID: 19854758
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer.
Hadaschik BA; ter Borg MG; Jackson J; Sowery RD; So AI; Burt HM; Gleave ME
BJU Int; 2008 Jun; 101(11):1347-55. PubMed ID: 18384637
[TBL] [Abstract][Full Text] [Related]
12. Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice.
Sarraf-Yazdi S; Mi J; Dewhirst MW; Clary BM
J Surg Res; 2004 Aug; 120(2):249-55. PubMed ID: 15234220
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an orthotopic rat bladder urothelial cell carcinoma model by cystoscopy.
Hendricksen K; Molkenboer-Kuenen J; Oosterwijk E; Hulsbergen-van de Kaa CA; Witjes JA
BJU Int; 2008 Apr; 101(7):889-93. PubMed ID: 18201266
[TBL] [Abstract][Full Text] [Related]
14. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735
[TBL] [Abstract][Full Text] [Related]
15. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.
Notting IC; Buijs JT; Que I; Mintardjo RE; van der Horst G; Karperien M; Missotten GS; Jager MJ; Schalij-Delfos NE; Keunen JE; van der Pluijm G
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1581-7. PubMed ID: 15851554
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model.
Xiao Z; McCallum TJ; Brown KM; Miller GG; Halls SB; Parney I; Moore RB
Br J Cancer; 1999 Oct; 81(4):638-46. PubMed ID: 10574249
[TBL] [Abstract][Full Text] [Related]
17. GFP image analysis in the mouse orthotopic bladder cancer model.
De Velasco MA; Tanaka M; Anai S; Tomioka A; Nishio K; Uemura H
Oncol Rep; 2008 Sep; 20(3):543-7. PubMed ID: 18695904
[TBL] [Abstract][Full Text] [Related]
18. Non-viral tumor necrosis factor-alpha gene transfer decreases the incidence of orthotopic bladder tumors.
Zang Z; Mahendran R; Wu Q; Yong T; Esuvaranathan K
Int J Mol Med; 2004 Oct; 14(4):713-7. PubMed ID: 15375606
[TBL] [Abstract][Full Text] [Related]
19. A novel rat model for glioblastoma multiforme using a bioluminescent F98 cell line.
Bryant MJ; Chuah TL; Luff J; Lavin MF; Walker DG
J Clin Neurosci; 2008 May; 15(5):545-51. PubMed ID: 18378459
[TBL] [Abstract][Full Text] [Related]
20. Prevention of bladder tumor formation in mice by a novel bone marrow-derived factor, reptimed.
Khandaker MH; Kadhim SA; Ichim TE; Howson-Jan K; Chin J; Singhal SK
Anticancer Res; 2000; 20(1A):183-9. PubMed ID: 10769653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
